Related Experiment Video
Updated: Dec 30, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
High prevalence of parent-reported sleep problems in pediatric patients with acute lymphoblastic leukemia after
Lindsay M H Steur1, Martha A Grootenhuis2, Eus J W Van Someren3,4,5
1Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Insights
Pediatric acute lymphoblastic leukemia (ALL) patients experience higher rates of sleep problems post-induction therapy, as reported by parents. Parental distress and sleep issues predict these childhood sleep disturbances.
Area of Science:
- Pediatric Oncology
- Sleep Medicine
- Child Psychology
Background:
- Pediatric acute lymphoblastic leukemia (ALL) treatment, particularly the intensive induction phase, can significantly impact a child's well-being.
- Sleep disturbances are common in pediatric cancer patients but require further investigation after intensive therapy.
Purpose of the Study:
- To determine the prevalence and predictors of sleep problems in pediatric patients with ALL after induction therapy.
- To compare sleep problem rates in ALL survivors with those in healthy children.
Main Methods:
- Utilized the Children's Sleep Habits Questionnaire (CSHQ) for parent and self-reports, alongside actigraphy for objective sleep measures.
- Assessed parental sleep, distress, and parenting challenges using validated questionnaires.
- Compared sleep problem prevalence (Z-score > 1) in ALL patients to healthy controls and identified determinants of parent-reported sleep issues via regression models.
Main Results:
- Parents reported sleep problems in 38.0% of ALL patients, significantly higher than the 15.2% in healthy children (P < .001).
- Actigraphy revealed longer total time in bed and total sleep time in ALL patients compared to controls.
- Parenting problems, parental sleep issues, bedroom sharing, and child sleep medication use predicted higher parent-reported child sleep problems (27.4% explained variance).
Conclusions:
- Pediatric ALL survivors exhibit a higher prevalence of sleep problems post-induction therapy, primarily identified through parental reports.
- Parental factors, including sleep quality and distress, are significant predictors of sleep disturbances in children undergoing ALL treatment.
- Systematic monitoring and intervention for both child and parental sleep are crucial for improving the quality of life for pediatric ALL survivors.
Objective:
To assess sleep problems (prevalence and predictors) in pediatric patients with acute lymphoblastic leukemia (ALL) after the most intensive phase of therapy (induction).
Methods:
Patients (≥2 years) treated according to the Dutch ALL-11 protocol were included. Sleep was measured using parent-reports and self-reports (Children's Sleep Habits Questionnaire; CSHQ) and actigraphy. Parental sleep (Medical Outcome Study Sleep Scale) and distress and parenting problems (Distress Thermometer for Parents) were assessed with questionnaires. Z-scores were calculated for total CSHQ scores using age-appropriate scores of healthy Dutch children. The prevalence of sleep problems (defined as a Z-score > 1) in patients with ALL was compared to healthy children (chi-square tests). Actigraphic sleep estimates were collected in healthy Dutch children (n = 86, 2-18 years) for comparison with patients (linear regression). Determinants of parent-reported child sleep (total CSHQ Z-score) were identified with regression models.
Results:
Responses were collected for 124 patients (response rate 67%), comprising 123 parent-reports, 34 self-reports, and 69 actigraphy assessments. Parents reported sleep problems in 38.0% of the patients compared to 15.2% in healthy children (P < .001). Patients reported fewer sleep problems themselves: 12.1% compared to 15.8% in healthy children (P = .33). Total time in bed (B (95% CI): 22.89 (9.55-36.22)) and total sleep time (B (95% CI):16.30 (1.40-31.19)), as derived from actigraphy, were significantly longer in patients. More parent-reported child sleep problems were predicted by parenting problems, more parental sleep problems, bedroom sharing, and child's sleep medication use (explained variance: 27.4%).
Conclusions:
Systematic monitoring of child and parental sleep and implementation of effective interventions may be a gateway to improve quality of survival in pediatric ALL.
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Nightmares and Night Terrors
Nightmares...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Management of Insomnia

